UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
Clinical trial NCT06272253 · UNKNOWN
Trial details
- NCT number
- NCT06272253
- Sponsor
- Dr. Soetomo General Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2024-03-19
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.